1 / 1

Multiple Myeloma Market Size & Share

Multiple Myeloma Market

Manisha109
Download Presentation

Multiple Myeloma Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global multiple myeloma market reached USD 27.58 billion in 2024 and is projected to grow to USD 44.19 billion by 2032, with a 6.1% compound annual growth rate. Key findings from the market analysis: North America dominates with 58.3% market share in 2024, driven by high treatment demand and advanced therapeutics adoption Immunomodulators lead the drug class segments due to successful treatments like Revlimid Hospital pharmacies are the primary distribution channel due to intravenous drug administration requirements    Market drivers include: Rising multiple myeloma prevalence globally Strong pipeline of new therapeutics from companies like Regeneron Increasing product launches and regulatory approvals    Key challenges: High treatment costs limiting access in developing countries, with annual costs ranging from $5,800 for cyclophosphamide to $192,000 for Pomalyst  Recent developments include FDA approvals of: Sarclisa (isatuximab-irfc) in March 2020 Xpovio (selinexor) in July 2019   Report- Fortune Business Insights - Multiple Myeloma Market Size, Share & Trends Report, 2032 https://www.fortunebusinessinsights.com/multiple-myeloma-market-102693

More Related